Search

Home > New FDA Approvals > 085 - Symdeko for CF; Glatopa for MS; Female sexual arousal disorder product; Molgradex inhaled GM-CSF; New HPV test.
Podcast: New FDA Approvals
Episode:

085 - Symdeko for CF; Glatopa for MS; Female sexual arousal disorder product; Molgradex inhaled GM-CSF; New HPV test.
Category: Science & Medicine
Duration: 00:11:52
Publish Date: 2018-02-13 07:00:00
Description:

February 13, 2018

Please subscribe rate and review and visit our website at http://newfdaapprovals.com. Thanks!

1:22 FDA approves Vertex cystic fibrosis combination treatment https://www.vrtx.com/story/fda-approves-symdeko https://www.reuters.com/article/vertex-pharms-cysticfibrosis/update-1-u-s-fda-approves-vertex-cystic-fibrosis-combination-treatment-idUSL2N1Q21HC

3:15 Sandoz announces US FDA approval and launch of Glatopa® 40 mg/mL three times-a-week generic option for relapsing forms of multiple sclerosis https://www.prnewswire.com/news-releases/policy-public-interest-latest-news/fda-approval-list/

4:23 Daré Bioscience (DARE) enters pact for product with potential to receive first FDA approval for female sexual arousal disorder https://darebioscience.gcs-web.com/news-releases/news-release-details/dare-bioscience-inc-enters-license-and-collaboration-agreement

6:39 Savara Announces IND Approval for Expansion of Molgradex Phase 3 Study Into U.S. http://savarapharma.com/investors/press-releases/release/?id=2331789

7:50 FDA Approves New HPV Test that Detects and Identifies HPV Genotypes that put Women at High Risk for Cervical Cancer https://www.prnewswire.com/news-releases/fda-approves-new-hpv-test-that-detects-and-identifies-hpv-genotypes-that-put-women-at-high-risk-for-cervical-cancer-300597459.html

Brought to you by www.nascentmc.com. Please contact info@nascentmc.com
Total Play: 0